The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.